跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 聖軒
教授
統計學研究所
https://orcid.org/0000-0003-0714-2354
h-index
h10-index
h5-index
1292
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1147
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
366
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2010
2024
每年研究成果
概覽
指紋
網路
計畫
(11)
研究成果
(67)
獎項
(4)
類似的個人檔案
(6)
指紋
查看啟用 Sheng-Hsuan Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Mediation Analysis
100%
Smartphone Addiction
66%
Causal Effect
54%
Mobile Application
50%
Medical Internship
46%
Causal Mediation Analysis
44%
Smartphone Use
37%
Internship
34%
Multiple Mediators
33%
Path-specific Effect
32%
Taiwan
31%
Hepatocellular Carcinoma
30%
Medical Interns
29%
Time-varying Confounders
29%
Natural Indirect Effect
28%
Causal Mechanisms
28%
Phantom Ringing
27%
Phantom Vibration
27%
Survival Outcomes
27%
On-call Duty
27%
Thyroid Surgery
27%
Confidence Interval
27%
Mechanistic Interaction
27%
Effect Decomposition
25%
Diagnostic Criteria
25%
G-formula
24%
Mediating Effect
24%
Risk Factors
24%
Working Hours
22%
Time-varying Exposure
21%
Sufficient Component Cause Model
20%
Cardiac Autonomic Function
19%
Natural Direct Effect
19%
Thyroidectomy
18%
Cardiovascular and Cerebrovascular Diseases
18%
Occupational Disability
18%
Diabetic Foot
18%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
18%
Alanine Aminotransferase
18%
Type 2 Diabetic Patients
16%
Recurrent Laryngeal Nerve
16%
Hepatitis C Virus
15%
Moderation Analysis
15%
Voice Impairment
14%
Reinfection
14%
Intraoperative Neuromonitoring
13%
Glucagon-like
13%
A1 Receptor
13%
Receptor Agonist
13%
Interns
13%
Medicine and Dentistry
Mediator
30%
Thyroid Surgery
27%
Cardiovascular Disease
27%
Diabetes Mellitus
26%
Retrospective Study
25%
Thyroidectomy
22%
Cerebrovascular Disease
21%
Diseases
21%
Reinfection
18%
Sodium Glucose Cotransporter 2 Inhibitor
18%
Amputation
17%
Patient with Type 2 Diabetes
16%
Recurrent Laryngeal Nerve
15%
Neuromonitoring
13%
Glucagon-Like Peptide-1 Agonist
13%
Periprosthetic Joint Infection
11%
Antibiotics
11%
COVID-19
11%
Infection
10%
Arthroplasty
10%
Leg Amputation
9%
Revision Arthroplasty
9%
Pancreas Adenocarcinoma
9%
Diagnosis
9%
Restylane
9%
Glycemic
9%
Life Expectancy
9%
Two-Stage Revision
9%
Retrospective Cohort Study
9%
Drug Sensitivity
9%
Standardized Mortality Ratio
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Triple Negative Breast Cancer
9%
Peritonitis
9%
Organoid
9%
Head and Neck Squamous Cell Carcinoma
9%
Meta-Analysis
9%
Systematic Review
9%
Internal Medicine
9%
Ecological Study
9%
Urinary Tract Infection
9%
Treatment Response
9%
Neoadjuvant Chemotherapy
9%
Primary Tumor
9%
Circulating Tumor Cell
9%
Isoprenaline
9%
Hematoma
9%
Parkinson's Disease
9%
Spondylitis
9%
Vocal Folds
9%
